H Leipold
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Proteoglycans and glycosaminoglycans research 5
-
- Protein purification and stability 2
- Co-authors
- Andrea Leone‐Bay (7 shared papers)R Baughman (5 shared papers)Sam Milstein (4 shared papers)George Lust (3 shared papers)Rajesh Agarwal (3 shared papers)Duncan R. Paton (2 shared papers)Nancy Burton‐Wurster (3 shared papers)Donald Sarubbi (3 shared papers)
- Journals
- Pharmaceutical Research (3 papers)Journal of Controlled Release (2 papers)Biochemical and Biophysical Research Communications (1 paper)Pharmaceutical biotechnology (1 paper)Journal of Orthopaedic Research® (1 paper)
- Partner nations
- United StatesSwitzerlandIreland
In The Last Decade
H Leipold
15 papers receiving 393 citations
Peers
Comparison fields: 5 of 72
- Pharmaceutical Science 149
- Internal Medicine 38
- Equine 12
- Immunology and Allergy 37
- Cell Biology 72
Countries citing papers authored by H Leipold
This map shows the geographic impact of H Leipold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Leipold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Leipold more than expected).
Fields of papers citing papers by H Leipold
This network shows the impact of papers produced by H Leipold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Leipold. The network helps show where H Leipold may publish in the future.
Co-authors
The 25 scholars most cited alongside H Leipold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 68 | |
| 2 | 1997 | 63 | |
| 3 | 1998 | 50 | |
| 4 | 1998 | 38 | |
| 5 | 1989 | 36 | |
| 6 | 1996 | 35 | |
| 7 | 2000 | 29 | |
| 8 | Fibronectin as a marker for osteoarthritis. | 1987 | 28 |
| 9 | 2000 | 24 | |
| 10 | 1988 | 18 | |
| 11 | 1996 | 16 | |
| 12 | 1992 | 9 | |
| 13 | 1997 | 7 | |
| 14 | 1996 | 5 | |
| 15 | Modulation of fibronectin and proteoglycan synthesis by chondrocytes. | 1991 | 2 |
About H Leipold
H Leipold is a scholar working on Cell Biology, Molecular Biology, Rheumatology, Immunology and Allergy and Surgery, having authored 15 papers that have together received 428 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Cell Adhesion Molecules Research (4 papers), Advanced Drug Delivery Systems (3 papers), Protein purification and stability (2 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (149 citations), Internal Medicine (38 citations), Equine (12 citations), Immunology and Allergy (37 citations) and Cell Biology (72 citations). H Leipold has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Andrea Leone‐Bay, R Baughman, Sam Milstein, George Lust, Rajesh Agarwal, Duncan R. Paton, Nancy Burton‐Wurster, Donald Sarubbi, Brian R. Stoll and Ronald Goldberg. Their work appears in journals such as Pharmaceutical Research, Journal of Controlled Release, Biochemical and Biophysical Research Communications, Pharmaceutical biotechnology and Journal of Orthopaedic Research®.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.